393 related articles for article (PubMed ID: 29205621)
1. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
[TBL] [Abstract][Full Text] [Related]
2. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
Kim J; Moestue SA; Bathen TF; Kim E
Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
[TBL] [Abstract][Full Text] [Related]
3. αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
Kazmierczak PM; Schneider M; Habereder T; Hirner-Eppeneder H; Eschbach RS; Moser M; Reiser MF; Lauber K; Nikolaou K; Cyran CC
Invest Radiol; 2016 Nov; 51(11):746-755. PubMed ID: 27082316
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.
Moestue SA; Huuse EM; Lindholm EM; Bofin A; Engebraaten O; Mælandsmo GM; Akslen LA; Gribbestad IS
J Magn Reson Imaging; 2013 Nov; 38(5):1043-53. PubMed ID: 23908122
[TBL] [Abstract][Full Text] [Related]
6. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.
Shi Q; Pisani LJ; Lee YK; Messing S; Ansari C; Bhaumik S; Lowery L; Lee BD; Meyer DE; Daldrup-Link HE
Contrast Media Mol Imaging; 2013; 8(3):281-8. PubMed ID: 23606432
[TBL] [Abstract][Full Text] [Related]
11.
Wang Y; Liu H; Yao D; Li J; Yang S; Zhang C; Chen W; Wang D
J Nanobiotechnology; 2019 Oct; 17(1):105. PubMed ID: 31604441
[TBL] [Abstract][Full Text] [Related]
12. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
14. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory imaging with ultrasmall superparamagnetic iron oxide.
Matsushita T; Kusakabe Y; Fujii H; Murase K; Yamazaki Y; Murase K
Magn Reson Imaging; 2011 Feb; 29(2):173-8. PubMed ID: 20850245
[TBL] [Abstract][Full Text] [Related]
16. In vitro distinction between proinflammatory and antiinflammatory macrophages with gadolinium-liposomes and ultrasmall superparamagnetic iron oxide particles at 3.0T.
Khaled W; Piraquive J; Leporq B; Wan JH; Lambert SA; Mignet N; Doan BT; Lotersztajn S; Garteiser P; Van Beers BE
J Magn Reson Imaging; 2019 Apr; 49(4):1166-1173. PubMed ID: 30390366
[TBL] [Abstract][Full Text] [Related]
17. Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor K
Grøvik E; Redalen KR; Storås TH; Negård A; Holmedal SH; Ree AH; Meltzer S; Bjørnerud A; Gjesdal KI
J Magn Reson Imaging; 2017 Jul; 46(1):194-206. PubMed ID: 28001320
[TBL] [Abstract][Full Text] [Related]
18. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
Kim E; Kim J; Maelandsmo GM; Johansen B; Moestue SA
Magn Reson Med; 2017 Oct; 78(4):1513-1522. PubMed ID: 27888545
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
